Cargando…
Alternative Cell Sources for Liver Parenchyma Repopulation: Where Do We Stand?
Acute and chronic liver failure is a highly prevalent medical condition with high morbidity and mortality. Currently, the therapy is orthotopic liver transplantation. However, in some instances, chiefly in the setting of metabolic diseases, transplantation of individual cells, specifically functiona...
Autores principales: | Tricot, Tine, De Boeck, Jolan, Verfaillie, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140465/ https://www.ncbi.nlm.nih.gov/pubmed/32121068 http://dx.doi.org/10.3390/cells9030566 |
Ejemplares similares
-
Where Do We Stand?
Publicado: (1891) -
COVID-19 and liver injury: where do we stand?
por: Papadopoulos, Nikolaos, et al.
Publicado: (2020) -
Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019) -
Assessment of Liver Function With MRI: Where Do We Stand?
por: Río Bártulos, Carolina, et al.
Publicado: (2022) -
Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016)